From July 17, 2023 to September 30, 2023, the company has repurchased 5,958,154 shares, representing 0.75% for CNY 122.88 million. With this, the company has completed the repurchase of 5,958,154 shares, representing 0.75% for CNY 122.88 million under the buyback announced on July 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.64 CNY | -1.55% | +3.99% | +28.83% |
Apr. 26 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
Apr. 25 | Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+28.83% | 3.07B | |
-4.74% | 183B | |
-0.20% | 108B | |
-3.54% | 67.51B | |
+4.57% | 50.67B | |
+9.17% | 44.7B | |
+2.41% | 40.95B | |
+5.86% | 26.8B | |
+2.29% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- 300529 Stock
- News Jafron Biomedical Co.,Ltd.
- Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.